TIME’s Best Innovations of 2026 includes a special mention of Perimeter Medical Imaging AI’s (TSX-V: PINK; OTCQX: PYNKF) Claire OCT System.
Claire is the only FDA-approved imaging device that uses AI during breast cancer surgery to help surgeons see microscopic tissue structures—where cancer can be difficult to detect—in real time, for margin assessment.
Surgeons performing breast-conserving surgery have long faced a difficult challenge: remove too little tissue and risk leaving undetected cancer behind, or remove too much and potentially affect cosmetic results. Claire addresses that challenge through real-time visualization of tissue suspicious for disease, with AI identifying areas of concern in the operating room to help surgeons make more informed decisions while the patient is still in surgery.
In an August press release announcing the first health system commercial deployment of Claire, Dr. Teresa Reading, a breast surgeon at Intermountain Health LDS Hospital in Salt Lake City, stated, “Every breast surgeon wants to give their patient the best possible chance of completing treatment in a single surgery, but microscopic cancer can be difficult to identify in the operating room. Claire was incredibly simple to incorporate into my workflow. The AI quickly directed my attention to specific areas of concern, giving me an additional set of trained eyes and more information to guide my decisions during these procedures.”
Claire builds on Perimeter’s legacy S-Series OCT platform, which was cleared by the FDA for general tissue imaging and uses optical coherence tomography, a light-based imaging technology used in ophthalmology and cardiology. The wide field OCT provides real-time, cellular-level visualization of tissue, while the AI available in Claire sifts through the images generated during surgery to flag areas of concern.
